Coloplast (Germany) Today
| CBHD Stock | EUR 65.08 0.28 0.43% |
PerformanceWeakest
| Odds Of DistressLow
|
Coloplast is trading at 65.08 as of the 21st of February 2026. This is a 0.43 percent up since the beginning of the trading day. The stock's lowest day price was 64.26. Coloplast has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of November 2025 and ending today, the 21st of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany. The company has 207.37 M outstanding shares. More on Coloplast AS
Moving against Coloplast Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Coloplast Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Coloplast's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Coloplast or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Coloplast's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Coloplast's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| President | Allan Rasmussen | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
Coloplast's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Coloplast's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsColoplast utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Coloplast's leverage profile, showing how much of Coloplast's resources are funded through borrowing.
| |||||
Coloplast AS (CBHD) is traded on Frankfurt Exchange in Germany and employs 16,983 people. Coloplast is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast AS operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 207.37 M outstanding shares.
Coloplast AS has accumulated about 143.67 M in cash with 2.77 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68.
Check Coloplast Probability Of Bankruptcy
Ownership AllocationColoplast holds a total of 207.37 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Coloplast Ownership Details
Coloplast Historical Income Statement
Coloplast Stock Against Markets
Coloplast Stock Analysis Notes
About 30.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.38. Coloplast AS last dividend was issued on the 5th of December 2025. The entity had 5:1 split on the 19th of December 2012. Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany. For more info on Coloplast AS please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.Coloplast Quarterly Total Revenue |
|
Coloplast AS Investment Alerts
| Coloplast AS generated a negative expected return over the last 90 days | |
| Coloplast AS has high historical volatility and very poor performance | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Coloplast AS Hits New 12-Month Low - Should You Sell - MarketBeat |
Coloplast Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 14.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Coloplast Profitablity
Coloplast's profitability indicators refer to fundamental financial ratios that showcase Coloplast's ability to generate income relative to its revenue or operating costs. If, let's say, Coloplast is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Coloplast's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Coloplast's profitability requires more research than a typical breakdown of Coloplast's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Management Efficiency
Coloplast AS has return on total asset (ROA) of 0.0985 % which means that it generated a profit of $0.0985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2726 %, meaning that it generated $0.2726 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Coloplast's Non Current Assets Total are most likely to increase significantly in the upcoming years.Management at Coloplast AS focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 21st of February, Coloplast shows the Risk Adjusted Performance of (0.02), mean deviation of 2.04, and Standard Deviation of 4.67. Coloplast AS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Coloplast AS treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Coloplast AS is priced correctly, providing market reflects its regular price of 65.08 per share.Coloplast AS Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Coloplast AS Tanh Of Price Series is a hyperbolic price transformation function.
Coloplast Outstanding Bonds
Coloplast issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Coloplast Predictive Daily Indicators
Coloplast intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Coloplast stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Coloplast Forecast Models
Coloplast's time-series forecasting models are one of many Coloplast's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Coloplast without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.